Summit Therapeutics is upgraded to a 'Buy' following FDA acceptance of its BLA for ivonescimab + chemotherapy in EGFR-mutant ...
Community-based navigation and outreach—mammography coordination, mobile van awareness, seminars, and on-demand guidance—can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results